For the fiscal second quarter 2024, we expect:
- Total billings in the range of $2.335 billion to $2.385 billion, representing year-over-year growth of between 15% and 18%.
- Total revenue in the range of $1.955 billion to $1.985 billion, vs. consensus of $1.97B, representing year-over-year growth of between 18% and 20%.
- Diluted non-GAAP net income per share in the range of $1.29 to $1.31, vs. consensus of $1.25, using 339 million to 342 million shares outstanding.
For the fiscal year 2024, we expect:
- Total billings in the range of $10.7 billion to $10.8 billion, representing year-over-year growth of between 16% and 17%.
- Total revenue in the range of $8.15 billion to $8.20 billion, vs. consensus of $8.19B, representing year-over-year growth of between 18% and 19%.
- Non-GAAP operating margin in the range of 26% to 26.5%.
- Diluted non-GAAP net income per share in the range of $5.40 to $5.53, vs. consensus of $5.34, using 338 million to 343 million shares outstanding.
- Adjusted free cash flow margin in the range of 37% to 38%.